In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative requires all faculty and planners to disclose financial relationships with ineligible companies. All relevant financial relationships have been reviewed and mitigated to ensure that the content is free from commercial bias.
The following faculty and planners have disclosed relevant financial relationships with ineligible companies in the past 24 months.
Faculty:
Javier Cortés, MD, PhD
Head, International Breast Cancer Center
Director, IOB Institute of Oncology
Madrid, Spain
Consulting Fees: AbbVie, AstraZeneca, Bioasis, Biocon, BioInvent, BioNTech, Bliss Biopharmaceutical, Boehringer Ingelheim, BridgeBio, Circle Pharma, Clovis Oncology, Daiichi Sankyo, Delcath Systems, Inc., Eisai, Ellipses, Expres2ion Biotechnologies, GEMoaB, Gilead, Hexagon Bio, HiberCell, Jazz Pharmaceuticals, Leuko, Lilly, Menarini, Merck Sharp & Dohme, Novartis, Pfizer, Relay Therapeutics, Reveal Genomics, Roche, Scorpion Therapeutics, Seattle Genetics, Stemline Therapeutics, Zuellig Pharma, Zymeworks
Research: Ariad Pharmaceuticals, AstraZeneca, Baxalta GMBH/Servier Affaires, Bayer Healthcare, Eisai, F. Hoffmann-La Roche, Guardant Health, IQVIA, Merck Sharp & Dohme, Pfizer, Piqur Therapeutics, Queen Mary University of London, Roche
Ownership and Intellectual Property: Leuko (relative), MAJ3 Capital
Patents:
- Pharmaceutical combinations of a Pi3k Inhibitor and a microtubule destabilizing agent. Javier Cortés Castán, Alejandro Piris Giménez, Violeta Serra Elizalde. WO 2014/199294 A. ISSUED
- Her2 as a predictor of response to dual HER2 blockade in the absence of cytotoxic therapy. Aleix Prat, Antonio Llombart, Javier Cortés. US 2019/ 0338368 A1. LICENSED
Stephanie L. Graff, MD
Director, Breast Oncology
University Health Cancer Institute
Providence, RI, USA
Consultant/Speaker/Advisory Board: AstraZeneca, Daiichi Sankyo/AstraZeneca, Genentech, Lilly, Menarini, Novartis, Pfizer, Wolters Kluwe
Research: AstraZeneca/Daiichi Sankyo, Daiichi Sankyo, Jazz Pharmaceuticals, Lilly, Novartis
Stock Ownership: HCA Healthcare
Reviewers/Planners/Authors:
- Cindy Davidson has no relevant relationships to disclose.
- Wilma M. Guerra has no relevant relationships to disclose.
- Brian P. McDonough, MD, FAAFP, has no relevant relationships to disclose.